It carves out several exceptions: uncontrolled hyperthyroidism, recent thyroid surgery, thyroid cancer or elevated calcitonin, where it says to avoid GLP-1 therapy or work through the risks with an endocrinologist first
We also highlight some of the cellular and animal models currently used in Parkinson research, such rotenone, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and paraquat as inducers, which have many similar features with this disease
Although preliminary data are encouraging, especially regarding the reduction of inflammation and body weight, open questions remain regarding the effects of these drugs on a longer time scale and on different patient subgroups
Liraglutide is also used to lower the risk of having a heart attack, stroke, or dying in persons who have type 2 diabetes and heart disease
Just open and honest conversations about risks and benefits of choices made.